CI

At a glance

ClinicalIndex Comparison Record
Early Ph 1Completed· 42 enrolled
Drug / intervention
Furosemide +1 moredrug
Likely dose
Furosemide 0.1mg/kgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05098366
NCT05098366Early Ph 1Completed

Utilization of Furosemide to Expedite Bladder Filling in Pediatric Females With Suspected Ovarian Torsion Awaiting Pelvic Ultrasound

Connecticut Children's Medical Center·interventional·Posted Oct 28, 2021·Updated May 31, 2024

In Brief

A Early Phase 1 clinical trial evaluating Furosemide and Normal saline for Ovarian Torsion. Completed, enrolled 42 participants across 1 site.

Detailed Summary

The purpose of this study is to investigate whether or not furosemide causes the bladder to fill faster than IV fluids alone so that a pelvic ultrasound exam can be performed.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsOvarian Torsion
CountriesUnited States
Collaborators--

Timeline

Early Ph 1CompletedFinished
20222023202420252026
First PostedOct 28, 2021
Enrollment StartMay 29, 2021
Primary CompletionDec 31, 2023
TodayJul 2, 2026
Enrollment to primary: 2.6 yearsPosted 4.7 years ago

Interventions

Furosemidedrug

0.1mg/kg (max 5mg) of IV furosemide

Normal salinedrug

20mL/kg (max 1000mL) normal saline bolus plus a normal saline flush